STOCK TITAN

Director Qiu Yu Min joins SINOVAC BIOTECH (SVA) as reporting insider on Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

SINOVAC BIOTECH LTD director Qiu Yu Min filed an initial Form 3, which is a required disclosure of insider status. This filing reports no transactions in the company’s securities and no derivative holdings, serving only to register Qiu Yu Min as a reporting insider.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
QIU YU MIN

(Last)(First)(Middle)
901, JIN BAO TOWER
89 JINBAO STREET, DONG CHENG

(Street)
BEIJING100005

(City)(State)(Zip)

CHINA

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
SINOVAC BIOTECH LTD [ SVA ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24 - Power of Attorney
No securities are beneficially owned.
/s/ Jia Zhao, Attorney-in-Fact03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the SINOVAC BIOTECH (SVA) Form 3 for Qiu Yu Min show?

The Form 3 for SINOVAC BIOTECH (SVA) shows that Qiu Yu Min is a director and an insider. It reports no purchases, sales, or derivative positions, serving only as an initial ownership disclosure.

Did Qiu Yu Min buy or sell SINOVAC BIOTECH (SVA) shares in this Form 3?

No, this Form 3 for SINOVAC BIOTECH (SVA) reports zero transactions. The summary fields show no buys, no sells, and no derivative exercises, indicating it is purely an initial registration filing.

Why did SINOVAC BIOTECH (SVA) file a Form 3 for Qiu Yu Min?

SINOVAC BIOTECH (SVA) filed a Form 3 because Qiu Yu Min is a director and therefore a reporting insider. Form 3 establishes this status with the SEC, even when no transactions are reported.

Does the SINOVAC BIOTECH (SVA) Form 3 indicate any derivative holdings for Qiu Yu Min?

No, the Form 3 derivative summary for SINOVAC BIOTECH (SVA) is empty. It shows no options, warrants, or other derivative securities reported for Qiu Yu Min at the time of this filing.

What does a zero transaction count on the SINOVAC BIOTECH (SVA) Form 3 mean?

A zero transaction count on the SINOVAC BIOTECH (SVA) Form 3 means the insider has not reported any recent trades. It simply records insider status without changing the public float or signaling trading activity.
Sinovac Biotech Ltd

NASDAQ:SVA

View SVA Stock Overview

SVA Rankings

SVA Latest News

SVA Latest SEC Filings

SVA Stock Data

642.44M
15.83M
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
China (Mainland)
Beijing